战略性新兴产业载体配置研究

科研管理 ›› 2015, Vol. 36 ›› Issue (4): 73-81.

战略性新兴产业载体配置研究

张志彤¹, 李天柱², 银路¹, 马佳²

1. 电子科技大学经济与管理学院, 四川成都 610054;
2. 辽宁科技大学工商管理学院, 辽宁鞍山 114051

收稿日期:2013-06-25 修回日期:2014-12-26 出版日期:2015-04-25 发布日期:2015-04-18
作者简介:张志彤(1972-),男(汉),广东新会人,电子科技大学经济与管理学院博士研究生。
研究方向:新兴技术管理、技术创新管理。
李天柱(1975-),男(汉),辽宁沈阳人,管理学博士。
辽宁科技大学工商管理学院副教授,电子科技大学经济与管理学院博士后。
研究方向:现代生物技术管理,技术创新管理,新兴技术管理。
基金资助:
国家自然科学基金项目“接力创新的模型及实证应用研究:以生物制药为例(71372121)”,2014年1月-2017年12月;国家自然科学基金青年基金项目“新兴技术演化情境识别及其对企业创新策略组合有效性的影响研究(71302083)”,2014年1月-2016年12月;教育部人文社会科学研究项目青年基金项目“生物技术产业集群创新支撑体系培育及其推广研究(12YJC630102)”,2012年7月-2015年6月;国家社会科学基金青年基金项目“生物技术企业创新中的知识产权策略研究:基于创新“接力”过程的博弈分析(12CGL016)”,2013年1月-2015年12月。

A study on industrial carrier allocation in strategic emerging industries

Zhang Zhitong¹, Li Tianzhu², Yin Lu¹, Ma Jia²

1. School of Management and Economics, University of Electronic Science &Technology of China, Chengdu 610054, Sichuan, China;
2. School of Business Administration, University of Science and Technology, Anshan 114051, Liaoning, China

Received:2013-06-25 Revised:2014-12-26 Online:2015-04-25 Published:2015-04-18

摘要/Abstract

摘要： 针对当前关于战略性新兴产业载体配置研究的薄弱,提出依据新兴技术向产业演进的规律为其配置载体。采用理论分析结合案例研究的方法,将战略性新兴产业演进分为孕育、成长和发展三个阶段,根据不同阶段对载体的需求构建载体配置模型,从软载体和硬载体之间的协同出发分析了战略性新兴产业载体的配置规律。结合生物制药产业具有的“接力创新”、“科学商业”等特性,运用论文的模型实证分析了生物制药产业的载体配置策略。

关键词: 产业载体, 战略性新兴产业, 载体配置模型, 生物制药, 协同效应

Abstract: To improve current research about industrial carrier allocation in strategic emerging industries, this study proposes to allocate the carrier based on the rules in the evolution from emerging technologies to the industries. Adopting the methods of theoretical analysis and the case study, the evolution process of strategic emerging industries has been divided into three main steps, including gestation, growth and development. According to the specific and actual demands from industrial carriers in different steps, the industrial carrier allocation model in strategic emerging industries has been structured, and the rules of which has been analyzed from the synergy of soft and hard carriers. Combined with the characteristics of bio-pharmaceutical industrial innovation, like "relay innovation", "science business" and so on, the industrial carrier allocation strategies in bio-pharmaceutical industries are analyzed empirically based on the application of industrial carrier allocation model.

Key words: industrial carrier, strategic emerging industries, carrier allocation model, bio-pharmaceutical, synergy effects

中图分类号:

F062.3

张志彤, 李天柱, 银路, 马佳. 战略性新兴产业载体配置研究[J]. 科研管理, 2015, 36(4): 73-81.

Zhang Zhitong, Li Tianzhu, Yin Lu, Ma Jia. A study on industrial carrier allocation in strategic emerging industries[J]. Science Research Management, 2015, 36(4): 73-81.

参考文献

[1] 孟宪昌.产业载体论[J].河南财经学院学报,1991(2):49-53. Meng Xianchang. Study on the industrial carrier[J]. Economic Survey, 1991(2): 49-53. [2] 张志彤,李天柱,银路,马佳,王敏.战略性新兴产业载体分类研究[J].技术经济,2013,32(9):8-14,105. Zhang Zhitong, Li Tianzhu, Yin Lu, Ma Jia, Wang Min. Study on taxonomy of industrial carrier in strategic emerging industry[J]. Technology Economics, 2013, 32(9): 8-14,105. [3] Day G. S., Schoemaker P. J. H., Gunther. R. E.. Wharton on managing emerging technologies[M]. John Wiley & Sons, Inc., 2000. [4] 银路,王敏,萧延高等.新兴技术管理的若干新思维[J].管理学报,2005(3):277-280. Yin Lu, Wang Min, Xiao Yangao, etc.. New thinking on management of emerging technology[J]. Chinese Journal of Management, 2005(3): 277-280. [5] 冯长根.选择培育战略性新兴产业的几点建议[J].科技导报,2010,28,(9):19-21. Feng Changgen. A proposal on how to select newly developed strategic industries in national support program[J]. Science & Technology Review, 2010, 28(9): 19-21. [6] 贺正楚,吴艳.战略性新兴产业的评价与选择[J].科学学研究,2011,29(5):678-683. He Zhengchu, Wu Yan. Assessment index system and evaluating model of strategic emerging industries[J]. Studies in Science of Science, 2011, 29(5): 678-683. [7] 段小华.战略性新兴产业的投入方式、组织形式与政策手段[J].改革,2011(2):89-94. Duan Xiaohua. The input mode, organization form and policy means of strategic emerging industries[J].Reform, 2011(2): 89-94. [8] 方荣贵,银路,王敏.新兴技术向战略性新兴产业演化中的政府政策分析[J].技术经济,2010,29(12):1-6. Fang Ronggui, Yin Lu, Wang Min. Analysis on government policy in evolution process from emerging technology to strategic emerging industry[J]. Technology Economics, 2010, 29(12): 1-6. [9] 李天柱,银路,苗仁涛,冯薇,马佳.“科学商业”和“接力创新”研究:基于生物制药[J].科学学研究,2012,30(12):1881-1890. Li Tianzhu, Yin Lu, Miao Rentao, Feng Wei, Ma Jia. Study on the “science business” and “relay innovation”: Based on bio-pharmaceutical industry[J].Studies in Science of Science, 2012, 30(12): 1881-1890. [10] Gibbons, M., Limoges, C., Nowotny, H., Schwatzman, S., Scott, P., Trow, M.. The new production of knowledge[M]. London: Sage, 1994. [11] Etzkowitz, H. and Leytesdorff, L. Universities in the global economy: A triple helix of academic-industry-government relation[M]. London: Croom Helm, 1997. [12] Hey T., Tansley S., Tolle K.著.潘教峰,张晓林等译.第四范式:数据密集型科学发现[M].北京:科学出版社,2012.Hey T., Tansley S., Tolle K.. The fourth paradigm: Data-intensive scientific discovery[M]. Microsoft Corporation, 2009. [13] [挪]詹·法格博格,[美]戴维·莫利,[美]理查德·纳尔逊主编.柳卸林,郑刚,蔺雷等译.牛津创新手册[M].北京:知识产权出版社,2009. Fagerberg, J., Mowery, D. C., Nelson, R. R.. The oxford handbook of innovation[M].London: Oxford University Press, 2006. [14] 解学梅,曾赛星.科技产业集群持续创新系统运作机理:一个协同创新观[J].科学学研究,2008,26(4):838-845. Xie Xuemei, Zeng Saixing. Synergetic operational mechanism of continuous innovative system of S & T[J]. Studies in Science of Science, 2008, 26(4): 838-845. [15] 李天柱,银路,石忠国等.生物制药创新中的专家型公司与核心公司研究——兼论我国生物制药区域产业创新平台建设[J].中国软科学,2011(11):108-116. Li Tianzhu, Yin Lu, Shi Zhongguo, etc.. Study on the expert companies and core companies of bio-pharmaceutical innovation: Discussion on bio-pharmaceutical innovation platform of regional industry of China[J].China Soft Science, 2011(11): 108-116. [16] 李天柱,银路,程跃.现代生物技术的特性与企业技术选择[J].技术经济,2009,28(10):55-59. Li Tianzhu, Yin Lu, Cheng Yue. Characteristics of modern biological technology and technology choice of enterprises[J]. Technology Economics, 2009, 28(10): 55-59. [17] [美]小艾尔佛雷德·钱德勒著,罗仲伟译.塑造工业时代——现代化学工业和制药工业的非凡历程[M].北京:华夏出版社,2006. Chandler, A. D.. Shaping the industrial century: The remarkable story of the modern chemical and pharmaceutical industries[M]. MA: Harvard University Press, 2002. [18] Lowman, M., Trott, P., Hoecht, A., et al.. Innovation risk of outsourcing in pharmaceutical new product development[J].Technovation, 2012, 32: 99-109. [19] 宋思扬,楼士林.生物技术概论(第三版)[M].北京:科学出版社,2007. Song Siyang, Lou shilin. Introduction to biotechnology (3rd Edition)[M]. Beijing: Science Press, 2007. [20] 李天柱,马佳,梁萌萌,冯薇.接力创新的一般规律与应用价值——以生物制药产业为例[J].技术经济,2012,31(11):9-13,30. Li Tianzhu, Ma Jia, Liang Mengmeng, Feng Wei. General law of application value of relay innovation: Case of biopharmaceutical industry[J]. Technology Economics, 2012, 31(11): 9-13, 30. [21] 李天柱,银路.现代生物技术的管理特征及我国企业现阶段的发展思路[J].科学学与科学技术管理,2009(6):130-134. Li Tianzhu, Yin Lu. The management characteristics of modern biotechnology and the development thinking of chinese corporations at present[J]. Science of Science and Management of S. & T., 2009(6): 130-134. [22] 陈劲,朱学彦.学术型创业家与企业绩效研究[J].中国软科学, 2006(4): 124-129. Chen Jin, Zhu Xueyan. Study on the relationship between academic entrepreneur and enterprise's performance[J]. China Soft Science, 2006(4): 124-129. [23] 李天柱,银路,程跃.美国生物制药企业的发展路径研究及其启示[J].中国软科学,2010(5): 136-142,181. Li Tianzhu, Yin Lu, Cheng Yue. Study on the development path of american biotechnology pharmaceutical enterprises and its revelation[J]. China Soft Science, 2010(5): 136-142, 181.